KCTD10 and gastrointestinal stromal tumor: Kaplan–Meier survival analysis revealed that KCTD10 expression in GIST was significantly correlated with the DFS rate, which was 85.62% and 52.17% for KCTD10-positive and -negative cases, respectively (p <0.0001; log-rank test, Figure 2B).